RANCHO CORDOVA, Calif., Dec. 5, 2019 /PRNewswire/ -- ThermoGenesis Holdings, Inc. THMO a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced Chris Xu, Ph.D., Chairman and Chief Executive Officer, will present a company overview at the LD Micro 12th Annual Main Event at the Luxe Sunset Boulevard Hotel in Los Angeles, California on Wednesday, December 11, at 1:20 pm PT.
Management will also be available for one-on-one meetings with qualified investors. Interested parties can register and request meetings through the LD Micro Conference portal or contact Rx Communications to schedule a meeting.
A live webcast of the presentation will be available on the ThermoGenesis website at https://ThermoGenesis.com/investors/news-and-events/events-webcasts. An archived replay will be available for a period of 90 days after the conference.
About ThermoGenesis Holdings, Inc.
ThermoGenesis Holdings, Inc., formerly known as Cesca Therapeutics Inc., develops, commercializes and markets a range of automated technologies for CAR-T and other cell-based therapies. The Company currently markets a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally closed CAR-TXpress™ platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. For more information about ThermoGenesis, please visit: www.ThermoGenesis.com.
Company Contact:
Wendy Samford
916-858-5191
ir@ThermoGenesis.com
Investor Contact:
Paula Schwartz, Rx Communications
917-322-2216
pschwartz@rxir.com
SOURCE ThermoGenesis Holdings, Inc.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.